"The greatest wealth is health."         - Virgil

      Advertisement

Our Experts answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question? Ask Our Experts!

Vaccine Safety

Menu

• Home
• Ask our Experts about XALATAN
• Ask Community about XALATAN
• XALATAN Usage
• Patients Wiki
• Share Your Health Story
• Take a Survey
• Health Blogs

More Resources

• Federal Food and Drug Administration
• Hospital Quality Reports
• Home Care Quality

XALATAN Safety Questions, XALATAN Answers

More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about XALATAN. Our extensive database of XALATAN adverse events and XALATAN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements

Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about XALATAN

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet

Type your question here

 letters left

XALATAN Safety Reports

Total XALATAN reports: 416.
XALATAN FDA safety alerts: No.
Reported deaths: 3    Reported hospitalizations: 55.
Take XALATAN Side Effects Survey or Share Your XALATAN Story. XALATAN Usage.

Showing 1-75 of 416 Next >

Consumer or non-health professional from GERMANY reported XALATAN problem on Apr 04, 2007. Male patient, 68 years of age, was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: intraocular pressure increased. XALATAN dosage: unknown. During the same period patient was treated with TRUSOPT. Patient recovered.

XALATAN problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 05, 2007. Female patient, weighting 179.9 lb, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: back pain, blood cholesterol increased, bronchitis, hair colour changes, hot flush, hyperhidrosis, insomnia, musculoskeletal pain, neuropathy. XALATAN dosage: unknown. During the same period patient was treated with PRAVACHOL, TRILEPTAL, VITAMIN B, STARLIX, TIMOLOL MALEATE, INSULIN. Patient recovered.

Health Professional from FRANCE reported XALATAN problem on Apr 06, 2007. Male patient, 79 years of age, was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: antinuclear antibody positive, uveitis. XALATAN dosage: unknown. During the same period patient was treated with MODOPAR. Patient was hospitalized. Patient recovered.

XALATAN problem was reported by a Consumer or non-health professional from FRANCE on Apr 10, 2007. Female patient, 70 years of age, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: neovascularisation, retinal oedema. XALATAN dosage: unknown. During the same period patient was treated with VASTAREL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XALATAN problem on Apr 06, 2007. Female patient, weighting 205.0 lb, was diagnosed with sensation of pressure and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: cataract operation, discomfort, eye irritation, eye pain. XALATAN dosage: unknown. Patient recovered.

XALATAN problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 13, 2007. Female patient, weighting 119.9 lb, was diagnosed with glaucoma, medical device implantation, pruritus and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: cardiac pacemaker insertion, eye operation, pruritus. XALATAN dosage: unknown. During the same period patient was treated with NORVASC, ZYRTEC. Patient recovered.

Physician from UNITED STATES reported XALATAN problem on Apr 11, 2007. Female patient, weighting 119.9 lb, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: cataract, eyelid ptosis, pruritus, rash. XALATAN dosage: unknown. Patient recovered.

XALATAN problem was reported by a Pharmacist from JAPAN on Apr 11, 2007. Female patient, 76 years of age, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: dysstasia, vertigo. XALATAN dosage: unknown. Patient recovered.

Physician from CANADA reported XALATAN problem on Apr 12, 2007. Male patient, 65 years of age, was diagnosed with open angle glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: diplopia, extraocular muscle disorder, miosis, strabismus. XALATAN dosage: unknown. Patient recovered.

XALATAN problem was reported by a Physician from JAPAN on Apr 17, 2007. Male patient, 66 years of age, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: blepharitis allergic, eye swelling. XALATAN dosage: unknown. During the same period patient was treated with MIKELAN, PIVALEPHRINE. Patient recovered.

Physician from JAPAN reported XALATAN problem on Apr 17, 2007. Male patient, 73 years of age, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: corneal disorder, visual field defect. XALATAN dosage: unknown. During the same period patient was treated with TIMOPTIC. Patient recovered.

XALATAN problem was reported by a Physician from JAPAN on Apr 17, 2007. Female patient, 76 years of age, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: dysstasia, vertigo. XALATAN dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from UNITED KINGDOM reported XALATAN problem on Apr 18, 2007. Male patient, 76 years of age, was diagnosed with open angle glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: ectropion. XALATAN dosage: unknown. During the same period patient was treated with ALPHAGAN, TIMOLOL MALEATE, TRUSOPT. Patient was hospitalized. Patient recovered.

XALATAN problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 17, 2007. Male patient, weighting 288.8 lb, was diagnosed with intraocular pressure test and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, eye pain, eyelid function disorder. XALATAN dosage: unknown. During the same period patient was treated with LORATADINE, ASPIRIN, SIMVASTATIN, FUROSEMIDE, POTASSIUM ACETATE, CLOPIDOGREL, GLYBURIDE, ATENOLOL. Patient recovered.

Consumer or non-health professional from CANADA reported XALATAN problem on Apr 17, 2007. Male patient, 77 years of age, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: arrhythmia, dyspepsia, flatulence, weight decreased. XALATAN dosage: unknown. During the same period patient was treated with BRIMONIDINE TARTRATE, AZOPT. Patient recovered.

XALATAN problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 18, 2007. Female patient, weighting 119.9 lb, was diagnosed with glaucoma, medical device implantation, pruritus and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: cardiac pacemaker insertion, eye operation, pruritus. XALATAN dosage: unknown. During the same period patient was treated with NORVASC, ZYRTEC. Patient recovered.

Pharmacist from UNITED STATES reported XALATAN problem on Aug 17, 2006. Female patient, 59 years of age, was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: eye irritation, retinal pigmentation. XALATAN dosage: unknown. During the same period patient was treated with SYNTHROID, AMBIEN. Patient recovered.

XALATAN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 22, 2006. Female patient was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: diplopia, visual acuity reduced. XALATAN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported XALATAN problem on Apr 24, 2007. Female patient, 71 years of age, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: exophthalmos, eye swelling, ocular hyperaemia, skin discolouration. XALATAN dosage: unknown. During the same period patient was treated with HOMEOPATHIC PREPARATION. Patient recovered.

XALATAN problem was reported by a Physician from UNITED STATES on Apr 25, 2007. Male patient, weighting 149.9 lb, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, dizziness. XALATAN dosage: unknown. During the same period patient was treated with ZOCOR, CARDURA, ALPHAGAN, LEVOBUNOLOL. Patient recovered.

Consumer or non-health professional from PERU reported XALATAN problem on Apr 23, 2007. Female patient, 61 years of age, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: intraocular pressure increased. XALATAN dosage: unknown. Patient recovered.

XALATAN problem was reported by a Pharmacist from JAPAN on Apr 27, 2007. Male patient, 63 years of age, was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: epistaxis, nasal discomfort. XALATAN dosage: unknown. During the same period patient was treated with TIMOLOL MALEATE. Patient recovered.

Physician from UNITED STATES reported XALATAN problem on Apr 27, 2007. Female patient, weighting 145.1 lb, was diagnosed with intraocular pressure increased, ocular hypertension and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: upper limb fracture. XALATAN dosage: unknown. During the same period patient was treated with TRAVATAN. Patient recovered.

XALATAN problem was reported by a Consumer or non-health professional from UNITED STATES on May 02, 2007. Female patient, weighting 155.3 lb, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: cataract, intraocular pressure increased, vision blurred. XALATAN dosage: unknown. During the same period patient was treated with ACTONEL, IBUPROFEN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XALATAN problem on May 02, 2007. Female patient, weighting 110.2 lb, was diagnosed with glaucoma, dementia and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: dementia. XALATAN dosage: unknown. During the same period patient was treated with FOSAMAX, VITAMIN CAP. Patient recovered.

XALATAN problem was reported by a Consumer or non-health professional from UNITED STATES on May 02, 2007. Female patient, weighting 110.2 lb, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: asthma, choking, postnasal drip, sinus disorder. XALATAN dosage: unknown. During the same period patient was treated with FOSAMAX, VITAMIN CAP, CALCIUM WITH VITAMIN D, ACETYLSALICYLIC ACID SRT, OMEGA, NAMENDA, ADVAIR DISKUS. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XALATAN problem on May 02, 2007. Female patient, weighting 110.2 lb, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: aortic valve atresia. XALATAN dosage: unknown. During the same period patient was treated with FOSAMAX, VITAMIN CAP. Patient recovered.

XALATAN problem was reported by a Consumer or non-health professional from UNITED STATES on May 02, 2007. Male patient, weighting 188.9 lb, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: diplopia, headache, vertigo, visual disturbance. XALATAN dosage: unknown. During the same period patient was treated with HYDROCHLOROTHIAZIDE, ACETYLSALICYLIC ACID SRT, ALPRAZOLAM, DIGITEK, WARFARIN. Patient recovered.

Physician from CANADA reported XALATAN problem on May 03, 2007. Male patient, weighting 179.9 lb, was diagnosed with open angle glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: diplopia, extraocular muscle disorder, miosis, strabismus. XALATAN dosage: unknown. Patient recovered.

XALATAN problem was reported by a Consumer or non-health professional from UNITED STATES on May 03, 2007. Male patient, weighting 190.4 lb, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: ear discomfort, mucous membrane disorder, rhinorrhoea, scotoma, visual field defect. XALATAN dosage: unknown. During the same period patient was treated with LUMIGAN, LOVASTATIN, LISINOPRIL, ATENOLOL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XALATAN problem on May 07, 2007. Female patient, weighting 160.9 lb, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: cautery to nose, epistaxis. XALATAN dosage: unknown. During the same period patient was treated with SYNTHROID, VITAMINS, HERBAL PREPARATION. Patient recovered.

XALATAN problem was reported by a Physician from CANADA on May 03, 2007. Male patient, weighting 179.9 lb, was diagnosed with open angle glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: diplopia, extraocular muscle disorder, miosis, strabismus. XALATAN dosage: unknown. Patient recovered.

Consumer or non-health professional from POLAND reported XALATAN problem on May 07, 2007. Female patient, 60 years of age, was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: hypersensitivity. XALATAN dosage: unknown. Patient recovered.

XALATAN problem was reported by a Pharmacist from JAPAN on May 07, 2007. Female patient, 36 years of age, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: premature labour. XALATAN dosage: unknown. During the same period patient was treated with MIKELAN, DETANTOL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported XALATAN problem on May 08, 2007. Male patient, 76 years of age, was diagnosed with open angle glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: blepharoplasty, conjunctival oedema, dermatitis, ectropion, erythema, periorbital oedema, skin exfoliation. XALATAN dosage: unknown. During the same period patient was treated with ALPHAGAN, TIMOLOL MALEATE, TRUSOPT. Patient was hospitalized. Patient recovered.

XALATAN problem was reported by a Physician from UNITED STATES on May 10, 2007. Female patient, weighting 115.1 lb, was diagnosed with open angle glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: acquired oesophageal web, chest discomfort, heart rate increased, hypothyroidism, musculoskeletal discomfort, oral discomfort. XALATAN dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from CANADA reported XALATAN problem on May 07, 2007. Female patient, weighting 227.1 lb, was diagnosed with intraocular pressure increased, blood pressure, tachycardia, blood cholesterol, hypersensitivity, depression, hypothyroidism and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: balance disorder, dizziness, hypotension. XALATAN dosage: unknown. During the same period patient was treated with LISINOPRIL, ATENOLOL, PANTOPRAZOLE, ZOCOR, METFORMIN, ATARAX, PAXIL, SYNTHROID. Patient recovered.

XALATAN problem was reported by a Physician from IRELAND on May 11, 2007. Female patient, 41 years of age, weighting 110.2 lb, was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, dizziness, energy increased, fatigue, flushing, heart rate increased, hypertrichosis, insomnia, memory impairment. XALATAN dosage: unknown. Patient recovered.

Physician from UNITED STATES reported XALATAN problem on May 10, 2007. Female patient, weighting 185.0 lb, was diagnosed with glaucoma, ill-defined disorder, hypertension, diabetes mellitus and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: blister, blood cholesterol, cardiac pacemaker insertion, lacrimation increased, pruritus. XALATAN dosage: unknown. During the same period patient was treated with LIPITOR, NORVASC, AVANDIA, AVALIDE, SYNTHROID, CENTRUM SILVER, GARLIC, FISH OIL. Patient was hospitalized. Patient recovered.

XALATAN problem was reported by a Consumer or non-health professional from UNITED STATES on May 10, 2007. Female patient, weighting 119.9 lb, was diagnosed with glaucoma, medical device implantation, pruritus and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: cardiac pacemaker insertion, eye operation, pruritus. XALATAN dosage: unknown. During the same period patient was treated with NORVASC, ZYRTEC. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported XALATAN problem on May 10, 2007. Male patient, 76 years of age, was diagnosed with open angle glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: blepharoplasty, conjunctival oedema, dermatitis, ectropion, erythema, periorbital oedema, skin exfoliation. XALATAN dosage: unknown. During the same period patient was treated with ALPHAGAN, TIMOLOL MALEATE, TRUSOPT. Patient was hospitalized. Patient recovered.

XALATAN problem was reported by a Consumer or non-health professional from BRAZIL on May 10, 2007. Female patient, weighting 121.3 lb, was diagnosed with ocular hypertension and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: intraocular pressure increased. XALATAN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XALATAN problem on May 12, 2007. Female patient, weighting 119.9 lb, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: cataract, eye burns, eye irritation, glaucoma surgery, lacrimation increased, weight increased. XALATAN dosage: unknown. Patient recovered.

XALATAN problem was reported by a Consumer or non-health professional from CANADA on May 07, 2007. Female patient, weighting 227.1 lb, was diagnosed with intraocular pressure increased, blood pressure, tachycardia, blood cholesterol, hypersensitivity, depression, hypothyroidism and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: balance disorder, dizziness, hypotension. XALATAN dosage: unknown. During the same period patient was treated with LISINOPRIL, ATENOLOL, PANTOPRAZOLE, ZOCOR, METFORMIN, ATARAX, PAXIL, SYNTHROID. Patient recovered.

Physician from UNITED STATES reported XALATAN problem on May 14, 2007. Female patient, 78 years of age, was diagnosed with abnormal sensation in eye and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: intraocular pressure test abnormal. XALATAN dosage: unknown. Patient recovered.

XALATAN problem was reported by a Consumer or non-health professional from UNITED STATES on May 15, 2007. Female patient, weighting 143.1 lb, was diagnosed with glaucoma, rheumatoid arthritis and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: disease progression, dry eye, glaucoma, hypoaesthesia, knee arthroplasty, peripheral nerve injury, therapeutic response unexpected, tibia fracture. XALATAN dosage: unknown. During the same period patient was treated with BEXTRA, TYLENOL, HYDROCHLOROTHIAZIDE, INDERAL. Patient was hospitalized. Patient recovered.

Physician from POLAND reported XALATAN problem on May 16, 2007. Female patient, weighting 154.3 lb, was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: conjunctival hyperaemia, conjunctival oedema, eyelid oedema, hypersensitivity. XALATAN dosage: unknown. During the same period patient was treated with ANTIHYPERTENSIVES. Patient recovered.

XALATAN problem was reported by a Consumer or non-health professional from UNITED STATES on May 16, 2007. Female patient, weighting 114.2 lb, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: cataract, eye irritation. XALATAN dosage: unknown. Patient recovered.

Consumer or non-health professional from ARGENTINA reported XALATAN problem on May 18, 2007. Female patient, weighting 103.6 lb, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: conjunctival irritation, eye injury, intraocular pressure increased, visual acuity reduced. XALATAN dosage: unknown. Patient recovered.

XALATAN problem was reported by a Health Professional from UNITED KINGDOM on May 18, 2007. Male patient, 76 years of age, was diagnosed with glaucoma, open angle glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: blepharoplasty, conjunctival oedema, dermatitis, ectropion, erythema, periorbital oedema, skin exfoliation. XALATAN dosage: unknown. During the same period patient was treated with TIMOLOL MALEATE, ALPHAGAN, TRUSOPT. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from BRAZIL reported XALATAN problem on May 21, 2007. Female patient was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: eye infection, intraocular pressure increased. XALATAN dosage: unknown. During the same period patient was treated with TANAKAN, TRUSOPT. Patient recovered.

XALATAN problem was reported by a Physician from UNITED KINGDOM on May 21, 2007. Male patient, 78 years of age, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: retinal detachment, vascular occlusion, venous stasis retinopathy, visual acuity reduced, vitreous detachment. XALATAN dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported XALATAN problem on May 23, 2007. Male patient, 76 years of age, was diagnosed with open angle glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: blepharoplasty, conjunctival oedema, dermatitis, ectropion, erythema, periorbital oedema, skin exfoliation, surgery. XALATAN dosage: unknown. During the same period patient was treated with ALPHAGAN, TIMOLOL MALEATE, TRUSOPT. Patient was hospitalized. Patient recovered.

XALATAN problem was reported by a Physician from POLAND on May 28, 2007. Female patient, weighting 154.3 lb, was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: conjunctival hyperaemia, conjunctival oedema, erythema of eyelid, eyelid oedema, eyelids pruritus, hypersensitivity, lacrimation increased, visual disturbance. XALATAN dosage: unknown. During the same period patient was treated with ANTIHYPERTENSIVES. Patient recovered.

Physician from UNITED STATES reported XALATAN problem on June 08, 2007. Male patient, 76 years of age, weighting 160.0 lb, was diagnosed with open angle glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: fall, renal failure. XALATAN dosage: unknown. During the same period patient was treated with IBUPROFEN, NIASPAN, ZOCOR, DIOVAN, ASPIRIN, AVODART, COREG. Patient was hospitalized. Patient recovered.

XALATAN problem was reported by a Consumer or non-health professional from UNITED STATES on May 29, 2007. Female patient, weighting 119.2 lb, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: alopecia, cataract, hair texture abnormal, herpes zoster. XALATAN dosage: unknown. During the same period patient was treated with SYNTHROID, TYLENOL, CALCIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported XALATAN problem on June 04, 2007. Male patient, 76 years of age, was diagnosed with open angle glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: blepharoplasty, conjunctival oedema, dermatitis, ectropion, erythema, periorbital oedema, skin exfoliation, surgery. XALATAN dosage: unknown. During the same period patient was treated with ALPHAGAN, TIMOLOL MALEATE, TRUSOPT. Patient was hospitalized. Patient recovered.

XALATAN problem was reported by a Consumer or non-health professional from BRAZIL on May 31, 2007. Female patient, 62 years of age, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: eye operation, gamma-glutamyltransferase increased, intraocular pressure increased, vision blurred. XALATAN dosage: unknown. Patient recovered.

Consumer or non-health professional from ARGENTINA reported XALATAN problem on June 01, 2007. Female patient, weighting 103.6 lb, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: conjunctival irritation, eye injury, intraocular pressure increased, visual acuity reduced. XALATAN dosage: unknown. Patient recovered.

XALATAN problem was reported by a Consumer or non-health professional from UNITED STATES on June 11, 2007. Female patient, weighting 220.5 lb, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: pruritus, skin discolouration. XALATAN dosage: unknown. During the same period patient was treated with TRUSOPT, METFORMIN, NEXIUM, LIPITOR, BENICAR, SINGULAIR, ADVAIR DISKUS, SALBUTAMOL. Patient recovered.

Pharmacist from JAPAN reported XALATAN problem on June 11, 2007. Female patient, 72 years of age, was diagnosed with hypertension and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: blood pressure increased. XALATAN dosage: unknown. During the same period patient was treated with ADALAT. Patient recovered.

XALATAN problem was reported by a Physician from GERMANY on June 11, 2007. Female patient, weighting 134.5 lb, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: arrhythmia, blood pressure abnormal, cardiovascular disorder. XALATAN dosage: unknown. Patient recovered.

Physician from LITHUANIA reported XALATAN problem on June 13, 2007. Female patient, 70 years of age, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: eye irritation, eye pruritus, intraocular pressure increased. XALATAN dosage: unknown. During the same period patient was treated with XALACOM, BETOPTIC. Patient recovered.

XALATAN problem was reported by a Consumer or non-health professional from UNITED STATES on June 12, 2007. Female patient, weighting 170.4 lb, was diagnosed with glaucoma, polymyalgia rheumatica and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, neutrophil count increased, white blood cell count increased. XALATAN dosage: unknown. During the same period patient was treated with PREDNISONE. Patient recovered.

Physician from LITHUANIA reported XALATAN problem on June 13, 2007. Male patient, 61 years of age, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: eye pruritus, intraocular pressure increased. XALATAN dosage: unknown. During the same period patient was treated with XALACOM. Patient recovered.

XALATAN problem was reported by a Physician from LITHUANIA on June 13, 2007. Female patient, 81 years of age, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: eye pruritus, intraocular pressure increased, vision blurred. XALATAN dosage: unknown. During the same period patient was treated with XALACOM. Patient recovered.

Physician from POLAND reported XALATAN problem on June 19, 2007. Female patient, weighting 154.3 lb, was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: conjunctival hyperaemia, conjunctival oedema, erythema of eyelid, eyelid oedema, eyelids pruritus, hypersensitivity, lacrimation increased, visual disturbance. XALATAN dosage: unknown. During the same period patient was treated with ANTIHYPERTENSIVES. Patient recovered.

XALATAN problem was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2007. Female patient, weighting 140.0 lb, was diagnosed with glaucoma, intraocular pressure increased and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: intraocular pressure increased. XALATAN dosage: unknown. During the same period patient was treated with ISOSORBIDE DINITRATE, COZAAR, HYDROCHLOROTHIAZIDE, SYNTHROID. Patient recovered.

Consumer or non-health professional from BRAZIL reported XALATAN problem on June 19, 2007. Female patient, weighting 154.3 lb, was diagnosed with glaucoma, hypertension, diabetes mellitus and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: depression, diabetes mellitus, dry mouth, dysphagia, eating disorder, mouth haemorrhage, oral pain, stomatitis, throat irritation. XALATAN dosage: unknown. During the same period patient was treated with VALSARTAN, SIMVASTATIN, NIFEDIPINE, INDAPAMIDE, INSULIN. Patient recovered.

XALATAN problem was reported by a Physician from GERMANY on June 21, 2007. Female patient, weighting 134.5 lb, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: arrhythmia, blood pressure abnormal, cardiovascular disorder. XALATAN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XALATAN problem on June 18, 2007. Female patient, weighting 156.3 lb, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: eye disorder. XALATAN dosage: unknown. During the same period patient was treated with NORVASC, ATENOLOL, PLAVIX, PROTONIX. Patient recovered.

XALATAN problem was reported by a Pharmacist from CANADA on June 18, 2007. Female patient, 55 years of age, was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: pain in extremity. XALATAN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XALATAN problem on June 22, 2006. Female patient, 73 years of age, was diagnosed with intraocular pressure increased and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, dizziness, eyelash thickening, gastric disorder, growth of eyelashes, incorrect dose administered, intraocular pressure increased, nausea, photopsia. XALATAN dosage: unknown. During the same period patient was treated with ATENOLOL, VITAMIN. Patient recovered.

XALATAN problem was reported by a Physician from FRANCE on June 22, 2006. Male patient, 75 years of age, was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: cataract operation, macular oedema, uveitis, visual disturbance. XALATAN dosage: unknown. During the same period patient was treated with CORTICOSTEROIDS, DORZOLAMIDE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XALATAN problem on June 28, 2006. Female patient, 78 years of age, was diagnosed with glaucoma and was treated with XALATAN. After drug was administered, patient experienced the following problems/side effects: bronchospasm, dyspnoea, incorrect dose administered, increased bronchial secretion. XALATAN dosage: unknown. During the same period patient was treated with AVAPRO, ZANTAC, CENTRUM, CALCIUM GLUCONATE, MAGNESIUM, ALBUTEROL. Patient recovered.

Showing 1-75 of 416 Next >

Ask Our Patient Community about XALATAN
Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has an active FDA Safety Alert
A Abacavir sulfate Abatacept Abilify Acamprosate calcium Accupril Accutane Aceon Aciphex Actiq (fentanyl citrate) Actimmune (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b) Actonel (risedronate) Actoplus Met (pioglitazone) Actos (pioglitazone) AcuTect (technetium Tc 99m apcitide) Adefovir dipivoxil Advair Diskus(Fluticasone propionate; Salmeterol xinafoate) Adderall (amphetamine salts) Agenerase (amprenavir) Aggrastat (tirofiban) Alamast (pemirolast) Alendronate Alemtuzumab Aleve (naproxen sodium) Alfuzosin Alinia (nitazoxanide) Alimta (pemetrexed) Alitretinoin Almotriptan malate Alosetron hydrochloride Aloxi (palonosetron) Alrex (loteprednol etabonate) Altace (ramipril) Ambien (zolpidem tartrate) Amerge (naratriptan) Aminolevulinic acid Amiodarone Amitiza (lubiprostone) Amnesteem (isotretinoin) Amphadase (hyaluronidase) luronidase) Amphetamine salts Amprenavir Anaprox (naproxen sodium) Angiomax (bivalirudin) Anidulafungin Antagon (ganirelix acetate) Anthelios SX (avobenzone, ecamsule, octocrylene) Apidra (insulin glulisine recombinant) Apokyn (apomorphine) Aprepitant Aprotinin Aptivus (tipranavir) Aranesp (darbepoetin alpha) Arava (leflunomide) Arformoterol Argatroban Aredia (pamidronate) Aripiprazole Arixtra (fondaparinux) Aromasin (exemestane) Arranon (nelarabine) Arsenic trioxide Aspirin Atacand (candesartan cilexetil) Atazanavir sulfate Atomoxetine Avastin (bevacizumab) Avelox (moxifloxacin) Avobenzone, Ecamsule, Octocrylene Avodart (dutasteride) Avonex (interferon beta-1a) Axert (almotriptan malate) Azacitidine Azilect (rasagiline) Azopt (brinzolamide) back to top B Balsalazide disodium Baraclude (entecavir) Benazepril Benicar (olmesartan medoxomil) Bevacizumab Bexarotene Bextra (valdecoxib) Biaxin (clarithromycin) Bimatoprost Bivalirudin Boniva (ibandronate) Bortezomib Brinzolamide Brovana (arformoterol) Bupropion Butisol sodium Byetta (exenatide) back to top C Calfactant Campath (alemtuzumab) Campral (acamprosate calcium) Cancidas (caspofungin) Candesartan cilexetil Capecitabine Capoten (captopril) Captopril Carbamazepine Carbatrol (carbamazepine) Carbrital (pentobarbital and carbromal) Caspofungin Cefditoren pivoxil Cefepime Ceftriaxone Celebrex (celecoxib) Celecoxib Celexa (citalopram hydrobromide) Cetrorelix acetate Cetrotide (cetrorelix acetate) Cetuximab Cevimeline Chantix (varenicline) Cialis (tadalafil) Cilostazol Cinacalcet Cirlesonide Citalopram Claravis (isotretinoin) Clarithromycin Clarinex (desloratadine) Clolar (clofarabine) Clofarabine Clozapine Clozaril (clozapine) Codeine Colazal (balsalazide disodium) Colesevelam Colistimethate Coly-Mycin M (colistimethate) Comtan (entacapone) Concerta (methylphenidate) Conivaptan Cordarone (amiodarone) Crestor (rosuvastatin calcium) Cubicin (daptomycin) Curosurf (poractant alfa) Cylert (pemoline) Cymbalta (duloxetine) Cytotec (misoprostol) back to top D Dacogen (decitabine) Dalfopristin Dalmane (flurazepam) Daptomycin Darbepoetin alpha Darifenacin Darunavir Dasatinib Daytrana (methylphenidate transdermal) DDAVP (desmopressin) DDAVP Nasal Spray (demopressin) DDAVP Rhinal Tube (desmopressin) DDVP (desmopressin Decitabine Deferasirox Definity (perflutren lipid microspheres) Depacon (valproate) Depakene (valproate) Depakote (valproate) Desloratadine Desmopressin Detrol (tolterodine tartrate) terodine tartrate) Dexedrine (dextroamphetamine sulfate) Dexmedetomidine Dexmethylphenidate HCl > Dextroamphetamine sulfate Diastat AcuDial Diazepam rectal gel Didronel (etidronate) Diprivan (propofol) Dofetilide Doral (quazepam) Doxercalcif Drospirenone Duloxetine Duragesic (fentanyl transdermal system) Dutasteride back to top E Eculizumab Edetate disodium Efalizumab Efavirenz Effexor (venlafaxine) Elestat (epinastine) Eletriptan Elidel (pimecrolimus) Ellence (epirubicin) Eloxatin (oxaliplatin) Emend (aprepitant) Emtricitabine Emtriva (emtricitabine) Enablex (darifenacin) Enalapril / Enalaprilat Endrate (edetate disodium) Enfuvirtide Entacapone Entecavir Epinastine Epirubicin Eplerenone Epoetin alfa Epogen (epoetin alfa) Eptifibatide Equetro (carbamazepine) Eraxis (anidulafungin) Erbitux (cetuximab) Ertaczo (sertaconazole) Escitalopram Estazolam Eszopiclone Ethchlorvynol Ethinyl estradiol Etidronate Evoxac (cevimeline) Exelon (rivastigmine tartrate) Exenatide Exjade (deferasirox) Exemestane Extraneal (icodextrin) Ezetimibe Ezetimibe/simvastatin back to top	F Factive (gemifloxacin mesylate) Faslodex (fulvestrant) Felbamate Felbatol (felbamate) Fentanyl buccal tablets Fentanyl citrate Fentanyl transdermal system Fentora (fentanyl buccal tablets) Ferrlecit (sodium ferric gluconate complex) Fleet Accu-Prep (sodium phosphate) Fleet Phospho-Soda (sodium phosphate) Fluoxetine Flurazepam Fluticasone propionate Fluvoxamine Focalin (dexmethylphenidate) Focalin XR (dexmethylphenidate) Fomivirsen Fondaparinux Foradil (formoterol fumarate) Formoterol fumarate Fosamax (alendronate) Fosinopril Frova (frovatriptan succinate) Frovatriptan succinate Fulvestrant Fuzeon (enfuvirtide) G Gabapentin Gabitril (tiagabine) Gadobenate Dimeglumine Gadodiamide Gadolinium Gadopentetate Dimeglumine Gadoteridol Gadoversetamide Galantamine Ganirelix acetate Gatifloxacin Gefitinib Gemifloxacin mesylate Gemtuzumab ozogamicin Geodon (ziprasidone) Gleevec (imatinib mesylate) back to top H Halcion (triazolam) Haldol (haloperidol) Haloperidol Hectorol (doxercalcif) Hepsera (adefovir dipivoxil) Hyaluronidase Hydase (hyaluronidase) Human Secretin back to top I Ibandronate Ibuprofen Icodextrin Iloprost Imatinib mesylate Increlex (Mecasermin [rDNA origin] Infasurf Preservative Free (calfactant) Imitrex (sumatriptan) Innohep (tinzaparin) Inspra (eplerenone) Insulin Aspart recombinant Insulin Detemir recombinant Insulin Glargine recombinant Insulin Glulisine recombinant Intron A (interferon alfa-2b) Integrilin (eptifibatide) ifibatide) Interferon alfa-2b Interferon beta-1a Interferon gamma-1b Invega (paliperidone) Iplex  (mecasermin rinfabate) Iressa (gefitinib) Isotretinoin back to top J Januvia (sitagliptin phosphate) back to top K Kaletra (lopinavir; ritonavir) Kepivance (palifermin) Keppra (levetiracetam) Ketek (telithromycin) Ketotifen fumarate back to top L Lamictal (lamotrigine) Lamotrigine Lantus (insulin glargine recombinant) Leflunomide Lenalidomide Lepirudin recombinant Levalbuterol Levemir (insulin detemir recombinant) Levetiracetam Levitra (vardenafil) Levonorgestrel Levothyroxine sodium Levulan Kerastick (aminolevulinic acid) Lexapro (escitalopram) Lindane Linezolid Lisinopril Lopinavir/ritonavir Lotemax (loteprednol etabonate) Lotensin (benazepril) Loteprednol etabonate Lotronex (alosetron hydrochloride) Lubiprostone Lucentis (ranibizumab) Lumigan (bimatoprost) Lunestra (eszopiclone) Lyrica (pregabalin) back to top M Macugen (pegaptanib) Magnevist (gadopentetate dimeglumine) Maraviroc Mavik (trandolapril) Maxalt (rizatriptan benzoate) Maxipime (cefepime) Mecasermin [rDNA origin] Mecasermin-rinfabate Meloxicam Memantine Metadate CD (methylphenidate HCl) ylphenidate HCl) Methylphenidate HCl Methylphenidate transdermal Mequinol Micafungin Micardis (telmisartan) misartan) Mifeprex (mifepristone) Mifepristone Miglustat Minirin (desmopressin) Mirtazapine Misoprostol Mobic (meloxicam) Modafinil Moexipril Monopril (fosinopril) Moxifloxacin MultiHance (gadobenate dimeglumine) Mycamine (micafungin) Mylotarg (gemtuzumab ozogamicin) back to top N Namenda (memantine) Naprosyn (naproxen) Naproxen Naratriptan Nesiritide recombinant Nateglinide Natrecor (nesiritide recombinant) Nefazodone Nelarabine NeoTect Kit (technetium Tc 99m depreotide) Nesiritide recombinant Neurontin (gabapentin) Nexavar (sorafenib) Nitazoxanide Nitisinone Norelgestromin NovoLog (insulin aspart recombinant) Noxafil (posaconazole) back to top O Olanzapine Olanzapine/fluoxetine Olmesartan medoxomil Omacor (omega-3-acid ethyl esters) Omalizumab Omega-3-acid ethyl esters Omnaris (cirlesonide) Omniscan (gadodiamide) OptiMARK (gadoversetamide) Optison (perflutren protein-type A microspheres) Orencia (abatacept) Orfadin (nitisinone) Orlistat Ortho Evra (norelgestromin; ethinyl estradiol) Oseltamivir phosphate Osmoprep (sodium phosphate) Oxaliplatin Oxcarbazepine back to top P Pacerone (amiodarone) Palifermin Paliperidone Pamidronate Panitumumab Panretin Gel (alitretinoin) Pantoprazole Paricalcitol Paroxetine Paxil (paroxetine) Pegaptanib Pegvisomant Pemetrexed Pemoline Pentobarbital and carbrom